# Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)

> **NCT03521310** · NA · TERMINATED · sponsor: **Björn Westrup, MD PhD** · enrollment: 91 (actual)

## Conditions studied

- Prematurity

## Interventions

- **PROCEDURE:** Skin-to-skin
- **PROCEDURE:** Conventional care

## Key facts

- **NCT ID:** NCT03521310
- **Lead sponsor:** Björn Westrup, MD PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-01
- **Primary completion:** 2021-10-12
- **Final completion:** 2021-10-12
- **Target enrollment:** 91 (ACTUAL)
- **Why stopped:** Continued randomization was questioned on ethical grounds after the WHO iKMC study reported mortality reduction in May 2021. The DSMB recommended to stop the trial after reviewing a preliminary data analysis because of benefit of the intervention.
- **Last updated:** 2022-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03521310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03521310, "Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03521310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*